01 1RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA
02 1Shanghai Wonder Pharmaceutical Co. Ltd.
03 1Spectrum Laboratory Products, Inc.
01 1DIMENHYDRINATE
02 2Dimenhydrinate
01 1China
02 1Italy
03 1U.S.A
NDC Package Code : 12711-4675
Start Marketing Date : 1982-07-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 55745-0002
Start Marketing Date : 2016-08-10
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49452-2615
Start Marketing Date : 1993-12-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
A Dimenhydrinate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dimenhydrinate, including repackagers and relabelers. The FDA regulates Dimenhydrinate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dimenhydrinate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Dimenhydrinate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Dimenhydrinate supplier is an individual or a company that provides Dimenhydrinate active pharmaceutical ingredient (API) or Dimenhydrinate finished formulations upon request. The Dimenhydrinate suppliers may include Dimenhydrinate API manufacturers, exporters, distributors and traders.
click here to find a list of Dimenhydrinate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Dimenhydrinate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Dimenhydrinate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Dimenhydrinate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Dimenhydrinate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Dimenhydrinate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Dimenhydrinate suppliers with NDC on PharmaCompass.
We have 3 companies offering Dimenhydrinate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
